![Greg Raskin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Greg Raskin
Corporate Officer/Principal bei
ROYALTY PHARMA PLC
Profil
Greg Raskin is Senior VP & Head-Academic Initiatives at Royalty Pharma Plc since 2026.
Formerly, Dr. Raskin was Director at Y-mAbs Therapeutics, Inc. from 2015 to 2020, Vice President at AllianceBernstein LP from 2005 to 2012, Analyst at Baker Bros.
Advisors LP in 2004, Manager at McKinsey & Co., Inc., Principal at New York University, Vice President-Technology Development at Memorial Sloan Kettering Cancer Center, and Principal at The Bellevue Hospital.
Education includes undergraduate and doctorate degrees from Yale University.
Aktive Positionen von Greg Raskin
| Unternehmen | Position | Beginn |
|---|---|---|
| ROYALTY PHARMA PLC | Corporate Officer/Principal | 03.08.2026 |
Ehemalige bekannte Positionen von Greg Raskin
| Unternehmen | Position | Ende |
|---|---|---|
| YMAS THER | Direktor/Vorstandsmitglied | 11.06.2020 |
AllianceBernstein LP
 AllianceBernstein LP Investment ManagersFinance AB is a research-driven investment adviser that is global in scope and client-centered in their approach. The firm’s global team of research professionals, whose disciplines include economics, fundamental equity, fixed income and quantitative research, gives them a competitive advantage in achieving investment success for their clients. Within these research disciplines, they also have investment professionals that focus on multi-asset, wealth management and alternative investment strategies. | Analyst-Equity | 17.10.2012 |
Baker Bros. Advisors LP
 Baker Bros. Advisors LP Investment ManagersFinance BBA pursues a fundamentally driven approach to life sciences investing. The firm typically takes large, concentrated positions in the securities of life sciences companies with the potential for significant value creation over the long-term. They focus on public securities, but may, from time to time, recommend investments in private companies, life sciences and related healthcare intellectual property, royalty streams or other non-public investment opportunities. | Corporate Officer/Principal | 31.12.2004 |
Memorial Sloan Kettering Cancer Center
 Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Operates as a nonprofit cancer hospital | Corporate Officer/Principal | - |
The Bellevue Hospital
 The Bellevue Hospital Medical/Nursing ServicesHealth Services Provides health care services | Corporate Officer/Principal | - |
Ausbildung von Greg Raskin
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
80
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Baker Bros. Advisors LP
Baker Bros. Advisors LP Investment ManagersFinance BBA pursues a fundamentally driven approach to life sciences investing. The firm typically takes large, concentrated positions in the securities of life sciences companies with the potential for significant value creation over the long-term. They focus on public securities, but may, from time to time, recommend investments in private companies, life sciences and related healthcare intellectual property, royalty streams or other non-public investment opportunities. | Finance |
AllianceBernstein LP
AllianceBernstein LP Investment ManagersFinance AB is a research-driven investment adviser that is global in scope and client-centered in their approach. The firm’s global team of research professionals, whose disciplines include economics, fundamental equity, fixed income and quantitative research, gives them a competitive advantage in achieving investment success for their clients. Within these research disciplines, they also have investment professionals that focus on multi-asset, wealth management and alternative investment strategies. | Finance |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Operates as a nonprofit cancer hospital | Health Services |
The Bellevue Hospital
The Bellevue Hospital Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
Y-mAbs Therapeutics, Inc.
 Y-mAbs Therapeutics, Inc. BiotechnologyHealth Technology Develops radioimmunotherapy and antibody-based oncology therapies for treating cancer | Health Technology |
Royalty Pharma Plc
 Royalty Pharma Plc Pharmaceuticals: MajorHealth Technology Buys and operates a portfolio of biopharmaceutical royalties | Health Technology |
